Recognizing Avoidant/Restrictive Food Intake Disorder (ARFID) as a serious feeding and eating disorder and acknowledging the urgent need to advance awareness, early identification, research, and equitable access to care.
Introduced June 11, 2026 · Last action June 11, 2026
Plain English Summary
This resolution recognizes Avoidant/Restrictive Food Intake Disorder (ARFID) as a serious eating disorder and calls on federal agencies, states, schools, and healthcare systems to improve early screening, diagnosis, provider training, and access to multidisciplinary treatment services. It does not create new funding, mandates, or legal requirements but expresses congressional support for advancing awareness, research, and equitable care access for individuals with ARFID.
Who benefits
Children and adults diagnosed with ARFID across all racial, ethnic, gender, and socioeconomic backgrounds; parents and families of individuals with ARFID; feeding therapists, speech-language pathologists, occupational therapists, nutritionists, and behavioral health specialists who treat ARFID; pediatricians and primary care providers who screen for early identification; autism advocacy organizations and autism spectrum disorder support networks (given the documented 14-fold increased likelihood of ARFID in autistic children); research institutions and universities conducting feeding disorder and neurodevelopmental research; school districts implementing accommodations; healthcare systems implementing screening and referral pathways.
Who pays / loses
No groups directly bear costs or lose existing benefits from this resolution, as it contains no appropriations, mandates with fiscal penalties, or removal of existing entitlements. However, implementation of recommendations would require resource expenditure from state and local education agencies, healthcare systems, and federal research agencies.
Funding & Lobbying Interests
Advocacy organizations focused on eating disorders (National Eating Disorders Association, feeding disorder-specific nonprofits), autism spectrum disorder organizations (Autism Society, autistic self-advocacy groups), pediatric medical associations, speech-language pathology and occupational therapy professional societies, and nutritionist and dietitian associations have financial and mission-based interests in advancing ARFID awareness and care access. Research institutions and universities stand to benefit from expanded research funding calls. School nutrition and special education sectors have operational interests in implementing accommodations. No sponsor finance data was provided.
Political Impact
Affected Groups
Children and adolescents with ARFID across all demographic groups, with particularly high rates among children with autism spectrum disorder (11 percent of autistic children meet ARFID criteria). Families managing ARFID in a household member. Healthcare providers, educators, and school personnel who screen for and accommodate ARFID. The bill text does not specify prevalence estimates in the general population, only comorbidity with autism.
Political Subtext
Proponents argue that ARFID is underrecognized and underdiagnosed despite being a serious, heritable neurodevelopmental condition with documented medical and psychosocial consequences, and that improved awareness, screening, and access to multidisciplinary care will reduce long-term harm and developmental delays. They emphasize the strong biological basis (79 percent heritability) to distinguish ARFID from behavioral or lifestyle issues. Critics would likely note that the resolution creates no new funding mechanisms and relies on voluntary agency action and educator implementation, raising questions about whether awareness alone translates to expanded services without budget allocations. Non-partisan evidence from the DSM-5 and pediatric research supports ARFID as a distinct diagnostic category with documented medical and developmental consequences; the 79 percent heritability figure is cited directly from Swedish twin study data referenced in the resolution.
Real-World Stakes
If the resolution is adopted and recommendations are acted upon, affected individuals would benefit from earlier identification in pediatric and primary care settings, reducing diagnostic delays that currently extend years in many cases. Schools would implement meal accommodations and support services for affected students, reducing stigma and nutritional risk in educational settings. Healthcare providers would receive clinical training to recognize ARFID presentations, improving diagnosis accuracy. Research funding would likely expand, potentially identifying new biological markers and interventions. However, absent accompanying appropriations or statutory requirements, implementation depends entirely on voluntary adoption by state and local agencies and healthcare systems. Analogous resolutions supporting early screening and multidisciplinary care for other eating disorders and neurodevelopmental conditions (e.g., autism screening mandates, dyslexia identification laws in multiple states since 2015) show that recognition alone often precedes resource allocation and sustained implementation by several years.
Sponsor
Sponsor information not available.
Vote Record
No recorded votes.
Campaign Finance — Primary Sponsor
No campaign finance data available yet.
501(c)(4) disclosure: Contributions from 501(c)(4) "dark money" organizations are not required to be publicly disclosed and are not reflected in the figures above. Data sourced from FEC public disclosure filings.
Community Discussion
Share this bill
Sign in to join the discussion.
No comments yet. Be the first.